SCHEMBL5377045

SCHEMBL5377045

CCCCOc1ccc(CSc2ccc(NS(=O)(=O)c3ccc(C)c(C(=O)OC)c3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.54
LMNA P02545 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 2/20 0.48
WDR5 P61964 2/20 0.48
TP53 P04637 1/20 0.48
PABPC1 P11940 1/20 0.47
HTT P42858 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ALDH1A1 P00352 4/20 0.45
MAPK1 P28482 1/20 0.44
MGAT2 Q10469 1/20 0.42
GLA P06280 1/20 0.42
KMT2A Q03164 1/20 0.42
CASP6 P55212 1/20 0.42
HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5375383 0.92 POLB (0.59) SMN1; SMN2LMNAPOLBMAPTWDR5
SCHEMBL5376792 0.88 SMN1; SMN2 (0.59) SMN1; SMN2LMNAPOLBMAPTWDR5
SCHEMBL5373887 0.86 POLB (0.49) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5376629 0.86 CASP6 (0.52) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5378678 0.84 POLB (0.50) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5382317 0.84 POLB (0.51) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5368417 0.83 ALOX15 (0.48) SMN1; SMN2POLBMAPTPABPC1HTT
SCHEMBL5368231 0.83 PLAU (0.53) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5382518 0.83 POLB (0.47) SMN1; SMN2LMNAPOLBMAPTPABPC1
SCHEMBL5375256 0.83 SMN1; SMN2 (0.62) SMN1; SMN2LMNAPOLBWDR5PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD SMN1; SMN2 3404/4885LMNA 319/4885POLB 1807/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD SMN1; SMN2 3296/4885LMNA 565/4885POLB 2006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.